News & Events
- May 24, 2017
-
May 22, 2017
miR-122 An Exploratory Biomarker of Liver Injury: An Industry Perspective on the State of the Science and Experiences Pre-Clinically and Clinically
The Critical Path Institute’s Predictive Safety Testing Consortium (PSTC) hosted a webinar focused on providing an industry perspective on the state of the science and preclinical and clinical experiences with mi-R122. This webinar was hosted by PSTC’s Hepatoxicity Working Group. The first presentation discussed the current state of miR-122 as a safety biomarker of liver...... - April 18, 2017
-
April 11, 2017
PTC Meets Its Deliverables
April 11, 2017 Dear Colleagues, In the fall of 2015 C-Path established the Pediatric Trials Consortium (PTC), with the goal of supporting the formation of a new, independent nonprofit organization that would develop a network of clinical trial sites with the specific capability to conduct registration-quality clinical trials for new medical products for children....... - April 5, 2017
